Oral Cancers Active Not Recruiting Phase 2 Trials for Durvalumab (DB11714)

Also known as: Cancer of the Mouth / Cancer of the Oral Cavity / Oral Cancer / Oral Cavity Cancer / Cancer of Mouth / Oral Cavity Neoplasm / Malignant Oral Cavity Neoplasm / Cancer, Mouth / Malignant oral cavity neoplasms / Mouth Cancer / Oral neoplasm malignant / Malignant neoplasm of mouth, unspecified / Primary malignant neoplasm of mouth (disorder) / Malignant tumor of oral cavity (disorder) / Malignant neoplasm of mouth NOS (disorder) / Lip and/or oral cavity cancer NOS / Lip and/or oral cavity cancer

IndicationStatusPhase
DBCOND0031962 (Oral Cancers)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03529422Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHNTreatment
NCT03174275Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell CarcinomaTreatment